Producing COVID-19 antibodies in hen eggs

hen eggs
Birds produce a form of antibody, IgY, found in eggs. UC Davis researchers have shown that quantities of IgY antibody specific for the COVID-19 virus spike protein can be produced from eggs by immunizing hens. Credit: Pixabay/CC0 Public Domain

Researchers at the University of California, Davis, have been able to produce antibodies to the SARS-CoV-2 spike protein in hen eggs. Antibodies harvested from eggs might be used to treat COVID-19 or as a preventative measure for people exposed to the disease. The work was published July 9 in the journal Viruses.

"The beauty of the system is that you can produce a lot of antibodies in birds," said Rodrigo Gallardo, professor in poultry medicine, Department of Population Health and Reproduction at the UC Davis School of Veterinary Medicine. "In addition to a low cost to produce these antibodies in hens, they can be updated very fast by using updated antigens to hyperimmunize hens, allowing protection against current variant strains."

Birds produce a type of antibody called IgY, comparable to IgG in humans and other mammals. IgY does not cause allergy or set off immune reactions when injected into humans. IgY appears both in birds' serum and in their eggs. As a hen lays about 300 eggs a year, you can get a lot of IgY, Gallardo said.

Gallardo and colleagues immunized hens with two doses of three different vaccines based on the SARS-CoV-2 spike protein or receptor binding domain. They measured antibodies in from the hens and in three and six weeks after the last immunization.

Purified antibodies were tested for their ability to block coronavirus from infecting at the National Center for Biodefense and Infectious Diseases at George Mason University in Virginia.

Both eggs and sera from immunized hens contained antibodies that recognized SARS-CoV-2. Antibodies from serum were more effective in neutralizing the virus, probably because there is more antibody in blood overall, Gallardo said.

Gallardo is working with colleagues Daria Mochly-Rosen at Stanford University and Michael Wallach, University of Technology, Sydney, to develop the egg-based antibody technology. The team hopes to deploy these in a preventative treatment such as a spray, that could be used by people at high risk of exposure to coronavirus.


Explore further

Common coronavirus infections don't generate effective antibodies against SARS-CoV-2

More information: Emily J. Aston et al, Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2, Viruses (2022). DOI: 10.3390/v14071510
Provided by UC Davis
Citation: Producing COVID-19 antibodies in hen eggs (2022, July 13) retrieved 6 October 2022 from https://phys.org/news/2022-07-covid-antibodies-hen-eggs.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
431 shares

Feedback to editors